fMRI-Neurofeedback for PTSD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people with PTSD, a condition that can develop after experiencing trauma, learn to control specific brain activities contributing to their symptoms. Participants will use real-time MRI biofeedback, a technique providing feedback on brain activity, to regulate brain areas like the amygdala and the posterior cingulate cortex, which are linked to PTSD. The study will compare the effects of this neurofeedback with sham feedback to determine its effectiveness in reducing PTSD symptoms. Individuals diagnosed with PTSD and comfortable using electronic devices might be a good fit for this trial. As an unphased trial, this study offers participants the chance to contribute to innovative research that could lead to new PTSD treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are using chronic opioid analgesics or have active substance use issues, you may be excluded from participating.
What prior data suggests that this fMRI neurofeedback technique is safe for PTSD patients?
Research has shown that fMRI neurofeedback is generally well-tolerated by people with PTSD. Participants in studies learned to control their brain activity through real-time feedback without major side effects. No one in these studies reported serious negative effects from the treatment, suggesting it is safe for use.
The treatment uses MRI technology to provide live feedback on brain activity, helping patients learn to change how their brains respond to stress. Although researchers are still studying the treatment, earlier studies have found no major safety issues. This is encouraging for those considering joining a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about using MRI neurofeedback for PTSD because it offers a unique, non-invasive way to directly influence brain activity. Unlike traditional treatments like therapy or medication, which often take time to show effects, MRI neurofeedback allows participants to receive real-time feedback on their brain activity, potentially leading to faster changes in brain patterns associated with PTSD. Specifically, this approach targets brain regions like the amygdala and the posterior cingulate cortex, which are crucial in processing emotions and self-reflection, respectively. By directly interacting with these brain areas, MRI neurofeedback could offer a new avenue for managing PTSD symptoms more effectively.
What evidence suggests that fMRI Neurofeedback might be an effective treatment for PTSD?
Research has shown that neurofeedback, a therapy where individuals learn to control their brain activity, can help reduce PTSD symptoms. Studies have found that this treatment offers moderate benefits for PTSD and can also improve related depression and anxiety. In this trial, participants will receive real-time fMRI neurofeedback, which uses brain scans to provide feedback, focusing on areas of the brain important for emotion and memory, such as the amygdala and the posterior cingulate cortex (PCC). Some participants will receive a sham neurofeedback signal as a control. Multiple studies support that this approach can lead to meaningful improvements, especially over time.24678
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 18-65 with PTSD, comfortable with tech like laptops and smartphones. Participants must have a PTSD diagnosis as per DSM-5 criteria but can also have depression or anxiety disorders. Exclusions include pregnancy, serious illnesses, MRI contraindications (like metal implants), neurological issues, untreated major illnesses, substance abuse in the last three months, claustrophobia, prior neurofeedback therapy or brain stimulation treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Clinical Assessment
Baseline clinical assessments including MINI and CAPS-5 to establish mental health disorder diagnoses and PTSD symptom severity
Self-report Assessments
Participants complete a battery of self-report questionnaires via REDCap
rt-fMRI Neurofeedback Sessions
3 rt-fMRI neurofeedback sessions over 3 weeks, including pre-session RSDI, localization scan, anatomical scan, resting-state scan, and task runs
Actigraphy Monitoring
Participants wear actigraphy devices to monitor biological rhythms and physical activity
Follow-up
Participants are monitored for changes in PTSD symptoms, interoceptive awareness, emotion regulation, and other measures at a 1-month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- MRI Biofeedback
- Sham-MRI Biofeedback
MRI Biofeedback is already approved in United States for the following indications:
- Post-traumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Andrew Nicholson
Lead Sponsor
McMaster University
Collaborator
Western University
Collaborator
University of Ottawa
Collaborator